The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreJun 2020
US$990Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Since 1984, incontinence towels have been included in the list of medical products offered by the Spanish health system. Therefore, these products can be purchased in chemists/pharmacies and medical centres under medical prescription, and consumers benefit from reimbursement.
The number of Spaniards suffering from incontinence continued to increase in 2019, pushing up sales in Rx/ reimbursement adult incontinence. On the one hand, over the review period the Spanish health system strongly invested in personnel able to identify incontinence, not only amongst the elderly, but also amongst younger people.
Manufacturers continued to invest in the creation of products offering greater flexibility and discretion to users. Towards the end of the review period, Essity launched its new Orlys Pants, which are thinner than previous products and have improved humidity absorption capacity to avoid infections.
Sales of Rx/reimbursement adult incontinence are expected to grow by 4% in constant 2019 value terms in 2020 in view of the impact of COVID-19. Some short-term disruptions to supply were witnessed at the beginning of the pandemic as the health system struggled with the onslaught of the virus, leading to an expected minor decline in volume growth in 2020 over the previous year.
However, demand remains strong and is likely to continue in this manner due to Spain’s aging population and the provision of these products on a reimbursement basis. Sales of both light and moderate/heavy incontinence were temporarily affected by the shortages at the beginning of the epidemic, although COVID-19 is unlikely to have any effect on either category going forward.
Sales of Rx/reimbursement adult incontinence are expected to register good growth over the forecast period. Demand will continue to be driven by the aging population in Spain and the health system’s provision of reimbursement on these products.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Files are delivered directly into your account within a few minutes of purchase.
Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement Adult incontinence industry in Spain with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Rx/Reimbursement Adult incontinence industry in Spain, our research will save you time and money while empowering you to make informed, profitable decisions.
The Rx/Reimbursement Adult incontinence in Spain market research report includes:
Our market research reports answer questions such as:
This industry report originates from Passport, our
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.